Literature DB >> 8509525

Depressive symptoms and measures of disability: a prospective study.

W Katon1, M Sullivan, J Russo, R Dobie, C Sakai.   

Abstract

OBJECTIVE: The purpose of this study was to test the hypothesis that decreases in severity of depressive symptoms in patients with chronic tinnitus would correlate with reductions in measures of functional disability.
METHOD: This study describes the correlations between several measures of functional disability and Hamilton depression scores in two groups of patients with major depression and depressive symptoms (D-NOS) who were patients enrolled in a 12-week placebo-controlled, double-blind trial of nortriptyline. These patients had chronic severe tinnitus which was associated in most patients with high frequency hearing loss. The effect of whether affective symptoms improved and the patient's initial depression status (major depression versus depressive symptoms) are examined in order to increase understanding about the correlations between depressive symptoms and functional disability.
RESULTS: Most measures of functional disability decreased synchronously with Hamilton Depression Scale scores in both patients with major depression and those with subclinical depressive symptoms. Patients whose depression improved had a significantly greater change in each disability measure than patients whose depression did not improve. This significant decrease in functional disability was seen in 11 of 13 scales in the improved D-NOS group, versus only 3 of the 13 scales in the unimproved D-NOS group; 9 of 13 scales of functional disability significantly decreased in the improved major depression group, versus 3 of 13 scales in the unimproved major depression group.
CONCLUSIONS: The results suggest that there was a significant correlation between improvement in both major depression and depression-NOS symptoms, and decreases in measures of functional disability in an aging population with a chronic medical illness.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509525     DOI: 10.1016/0165-0327(93)90048-o

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

Review 2.  Antidepressants for patients with tinnitus.

Authors:  Paolo Baldo; Carolyn Doree; Paola Molin; Don McFerran; Sara Cecco
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

3.  Quality of depression treatment in Black Americans with major depression and comorbid medical illness.

Authors:  Amma A Agyemang; Briana Mezuk; Paul Perrin; Bruce Rybarczyk
Journal:  Gen Hosp Psychiatry       Date:  2014-03-07       Impact factor: 3.238

4.  Roles of cognitive characteristics in tinnitus patients.

Authors:  So-Young Lee; Ji-Hae Kim; Sung-Hwa Hong; Dong-Soo Lee
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

Review 5.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

Review 6.  Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.

Authors:  Kenjiro Seki; Satomi Yoshida; Manoj Kumar Jaiswal
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.